Minimizing Risk and Maximizing Outcomes in Geriatric Patients Through Integrated Clinical Pharmacy Services in an Innovative Model of Community Practice
NCT01351441 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2020-06-04
Summary
It has been shown that patients can improve their safety through informed choice, safe medication use, and complication reporting. This includes not only the potential problems that occur from prescription medication use but also issues that may arise through the improper use of over-the-counter medications. The willingness of a patient to take on safety action is known to be complicated by an unwillingness to behave in a manner that might challenge a physician's judgment or actions. Community pharmacists are in the unique position to provide perspective on the physician's recommendation and act as an advocate to facilitate necessary change. Through supportive and repeated interaction with their community pharmacist patients will develop assertiveness toward their own health care, an increased frequency and quality of interaction with their physician, and thus a minimized risk of harm and maximized opportunity to optimize clinical outcomes.
Conditions
- Medication Adherence
- Health Literacy
- Geriatric Patient Care Improvement
- Pharmacy Economic Improvement
Interventions
- BEHAVIORAL
-
Medication adherence consultation
Patients will be counseled in person on day 0 then telephonically every month after until day 365.
- OTHER
-
Medication problems assessment
Patients will be asked if they are having any issues that may be attributable to their current drug therapy on a monthly basis. Any issue that is identified will be addressed by the pharmacist.
- OTHER
-
Beer's Criteria Assessment
The patient's drug therapy will be reviewed for Beer's criteria medications and possible alternatives will be addressed by the pharmacist if deemed appropriate.
- BEHAVIORAL
-
Health Literacy Assessment
Patients will be given a Health Literacy Assessment on day 0 and day 365 using the Realm-SF.
Sponsors & Collaborators
-
Community Pharmacy Foundation
collaborator OTHER -
VascuScript Pharmacy
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-05-31
- Primary Completion
- 2012-11-30
- Completion
- 2012-11-30
Countries
- United States
Study Locations
More Related Trials
-
Pharmacist Intervention to Decrease Medication Errors in Heart Disease Patients (The PILL-CVD Study)
NCT00632021 ·Status: COMPLETED ·Phase: NA
-
Improving Safety After Hospitalization in Older Persons on High-Risk Medications
NCT02781662 ·Status: COMPLETED ·Phase: NA
-
Community Pharmacy Assisting in Total Cardiovascular Health
NCT01509014 ·Status: UNKNOWN ·Phase: NA
-
Iatrogenic Drug Risk in People Over 75, With or Without Cognitive Disorders, From an Inventory of Their Family Pharmacy
NCT03686943 ·Status: WITHDRAWN
-
Impact of Pharmacist Post-discharge Phone Calls on Hospital Readmission and Patient Medication Literacy and Adherence
NCT02031406 ·Status: TERMINATED ·Phase: NA
-
Medication Histories Conducted by Nurses (RNs), Pharmacy Techs (CPhTs) & Pharmacists (RPhs)
NCT01065675 ·Status: TERMINATED ·Phase: NA
-
Optimizing Electronic Health Record Prompts With Behavioral Economics to Improve Prescribing for Older Adults
NCT04284553 ·Status: COMPLETED ·Phase: NA
-
Standardized Patient-Centered Medication Review in Home Hospice
NCT03972163 ·Status: COMPLETED ·Phase: NA
-
Pharmacy Home Adherence Reporting and Monitoring Outcomes Study
NCT02306122 ·Status: COMPLETED ·Phase: NA
-
Expanding the Role of Pharmacists in Treating Persons With Cardiovascular or Lung Diseases
NCT00513903 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Pharmacist Impact Study
NCT07269002 ·Status: COMPLETED ·Phase: NA
-
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
NCT02215408 ·Status: COMPLETED ·Phase: NA
-
Post-Discharge Follow-Up Phone Call by a Pharmacist and Impact on Patient Care
NCT00332514 ·Status: COMPLETED ·Phase: PHASE2
-
Proximity Work in Family Medicine Groups : the Impact of Pharmacists
NCT02963636 ·Status: COMPLETED ·Phase: NA
-
A Pharmacist Implemented Pharmacogenomics Service in the Program of All-inclusive Care for the Elderly
NCT03257605 ·Status: COMPLETED
-
The Impact of Pharmacist Recommendations on Quality of Care in Diabetic Patients
NCT00122421 ·Status: COMPLETED ·Phase: NA
-
Benefit of a Collaborative Approach to Improve the Quality of Medicines Use in Elderly Inpatients
NCT00279656 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacist-Led SDoH Screening Intervention During Transitions of Care in an Acute Care Setting
NCT06802393 ·Status: COMPLETED ·Phase: NA
-
Trial of a Pharmacist-physician Intervention Model to Reduce High-risk Drug Use by Hospitalised Elderly Patients
NCT02570945 ·Status: COMPLETED ·Phase: PHASE4
-
Health Information Technology in the Nursing Home
NCT00599209 ·Status: COMPLETED ·Phase: NA
-
Pharmacist-led Intervention on Hemodialysis Patients' Therapy Adherence
NCT06744738 ·Status: COMPLETED ·Phase: NA
-
Home Medication Reviews by Pharmacists in Ontario, Canada
NCT02658604 ·Status: COMPLETED
-
Enhanced Pharmacist-Managed Anticoagulation Service in a University-based Family Medicine Clinic
NCT03575936 ·Status: COMPLETED ·Phase: NA
-
Effect of a trAnSitional Pharmacist Intervention in geRiatric Inpatients on Hospitals Visits After dischargE
NCT04617340 ·Status: COMPLETED ·Phase: NA
-
Implementing Prescriber-Pharmacist Collaborative Care for Evidence-based Anticoagulant Use
NCT05351749 ·Status: COMPLETED ·Phase: NA